What's in Bent Gymoese Jorgensen's pipeline?

Bent Gymoese Jorgensen has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Bent Gymoese Jorgensen's portfolio?

Top competitors by shared drug class: Bnai Zion Medical Center, Conrad Arnfinn Bjørshol, Hamad Medical Corporation, National Institute for Tuberculosis and Lung Diseases, Poland.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/bent-gymoese-jorgensen.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Bent Gymoese Jorgensen — Portfolio Competitive Intelligence Brief

Bent Gymoese Jorgensen pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Naropin 0.1% cum sufentanil	Naropin 0.1% cum sufentanil	phase 3	Local anesthetic with opioid analgesic combination	Voltage-gated sodium channels (ropivacaine); mu-opioid receptor (sufentanil)	Anesthesia, Pain Management

Therapeutic area mix

Anesthesia, Pain Management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bnai Zion Medical Center · 1 shared drug class
Conrad Arnfinn Bjørshol · 1 shared drug class
Hamad Medical Corporation · 1 shared drug class
National Institute for Tuberculosis and Lung Diseases, Poland · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Bent Gymoese Jorgensen:

Cite this brief

Drug Landscape (2026). Bent Gymoese Jorgensen — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/bent-gymoese-jorgensen. Accessed 2026-05-16.